• Publié par : Fabienne LETELLIER-NICOLAS
  • Imprimer cette page

Publications

2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003

 

2004 

  • Bouet, F., Catros, V., Immune anticancer response: recent advances in the treatment of renal cell carcinoma. Ann Biol Clin. 2004. 62 : 257-268.
  • Drenou, B., Tilanus, M., Semana, G., Alizadeh, M., Birebent, B., Grosset, J. M., Dias, P., van Wichen, D., Arts, Y., De Santis, D., Fauchet, R., Amiot, L., Loss of heterozygosity, a frequent but a non-exclusive mechanism responsible for HLA dysregulation in non-Hodgkin's lymphomas. Br J Haematol. 2004. 127: 40-49. 
  • Le Friec, G., Gros, F., Sebti, Y., Guilloux, V., Pangault, C., Fauchet, R., Amiot, L., Capacity of myeloid and plasmacytoid dendritic cells especially at mature stage to express and secrete HLA-G molecules. J Leukoc Biol. 2004. 76: 1125-1133. 
  • Le Rond, S., Le Maoult, J., Creput, C., Menier, C., Deschamps, M., Le Friec, G., Amiot, L., Durrbach, A., Dausset, J., Carosella, E. D., Rouas-Freiss, N., Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients. Eur J Immunol. 2004. 34: 649-660.